Research on the treatment and prevention of malaria in pregnancy in sub-Saharan Africa: East Africa Regional Meeting

12 Jul 2016

11-12 July 2016 - Fairview Hotel - Nairobi, Kenya

For the full meeting report please click here.

Photos from the event can be viewed here.


Welcome and Introductions  

Malaria in Pregnancy Consortium:  Overview & Objectives of the Meeting
Feiko ter Kuile & Jenny Hill. Liverpool School of Tropical Medicine

Burden of Malaria in preganancy in the East Africa Region
Patrick Walker Imperial College London Data not published

Session 1: Use of ACTs for case management of malaria in all trimesters of pregnancy

Safety, efficacy and dosing of ACTs for treatment of clinical malaria in 2nd and 3rd trimesters in Africa
Michael Nambozi . Tropical Diseases Research Centre (TDRC), Zambia

Safety of ACTs and quinine in early pregnancy in Africa
Feiko ter Kuile . Liverpool School of Tropical Medicine . Data not published

Knowledge and adherence to national guidelines for malaria case management in pregnancy among helathcare providers and drug outlets in western Kenya
Simon Kariuki . Kenya Medical Research Institute (KEMRI)

Session 2: IPTp with 2 vs 3 or more doses of SP and the impact of SP resistance

Effectiveness and cost effectiveness of 2 vs 3+ doses of IPTp with SP
Feiko ter Kuile . Liverpool School of Tropical Medicine

Impact of SP resistance on the effectiveness of IPTp with SP in sub-Saharan Africa
Annemieke van Eijk. Liverpool School of Tropical Medicine . Data not published

Effectiveness of antenatal clinics to deliver IPTp-SP in contect of other ANC services
Jenny Hill. Liverpool School of Tropical Medicine

Experiences of implementing current MiP policies - national programme perspectives:
Peter Njim and Elizabeth Washika. Kenya Ministry of Health, National Malaria Control Programme
Diana Khonje & Shadreck Mulenga. Malawi Ministry of Health, National Malaria Control Programme
Baltazar Candrinho. Mozambique Ministry of Health, National Malaria Control Programme
Victor Chalwe. Zambia Ministry of Health

Session 3: Implications for current policies: Summary and discussion to end day 1

Session 4: Alternative drugs for UPTp and alternative screen and treat approaches (ISTp)  

Lessons learnt from IPTp with Mefloquine clinical trials in Benin, Gabon, Kenya, Mozambique and Tanzania
Raquel Gonzales IS Global   
Intermittent screening and treatment (ISTp) compared to IPTp-SP in Kenya and Malawi
Mwayi Madanitsa College of Medicine, Malawi
User and provider acceptability of alternative drugs for IPTp and ISTp under trial conditions in Ghana, Malawi and Kenya
Jayne Webster London School of Hygiene and Tropical Medicine.  Data not published

Session 5: Implications for national policies and programmes     

Potential challenges for MiP policy change and implementation of new policies - national programme perspectives: MOH Representative Thoughts and Presentations
Peter Njim and Elizabeth Washika Kenya Ministry of Health, National Malaria Control Programme
Diana Khonje & Shadreck Mulenga Malawi Ministry of Health, National Malaria Control Programme
Baltazar Candrinho Mozambique Ministry of Health, National Malaria Control Programme
Georgina Msemo Tanzania Ministry of Health
Victor Chalwe. Zambia Ministry of Health